Cytokinetics Inc (CYTK)

Days of sales outstanding (DSO)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
DSO	days	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —

To analyze Cytokinetics Inc.'s Days Sales Outstanding (DSO) based on the provided data, we observe that the DSO values are not provided, as indicated by the dash symbol for each reporting period from March 31, 2020, to December 31, 2024.

DSO is a financial metric that measures the average number of days a company takes to collect payment after a sale has been made. Typically, a lower DSO is favorable as it indicates faster collection of revenue, efficient credit management, and potentially healthier cash flows.

However, without specific DSO values for the periods mentioned, it is challenging to assess Cytokinetics Inc.'s efficiency in collecting payments from its customers over time. To properly evaluate the company's DSO trend and performance, actual DSO figures for each reporting period are required.

It is important to note that monitoring DSO can provide insights into a company's liquidity, credit policies, and effectiveness in managing receivables. A stable or decreasing DSO over time may indicate improved cash flow management and efficient collection processes, while an increasing DSO could signify potential liquidity challenges or issues with credit control.

Therefore, the absence of DSO data for Cytokinetics Inc. limits the ability to conduct a comprehensive analysis of its receivables management and cash flow efficiency based on this particular financial ratio.